Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Thursday, January 23, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Applied Aerospace Appoints David Myers as Chief Strategy Officer
ODW Logistics Unveils Global Shipping with Passport Partnership
VALID Therapeutics Teams with Araceli Biosciences for AI Drug Discovery
Encycle and Itron Collaborate to Boost Energy Management
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
CDK7 inhibitor
CDK7 inhibitor
Biotechnology
Exscientia acquires full rights to potential lead-in CDK7 inhibitor prior to publication of Phase 1 dose escalation data
News Desk
-
July 19, 2024
Exscientia plc announced that it has entered into an agreement to acquire GT Apeiron's interest in its oral CDK7 inhibitor program, thereby gaining full...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Applied Aerospace Appoints David Myers as Chief Strategy Officer
ODW Logistics Unveils Global Shipping with Passport Partnership
VALID Therapeutics Teams with Araceli Biosciences for AI Drug Discovery
Load more
